Clinical trial
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in…
NCT00349336 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00349336 |
|---|---|
| Title | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. |
| Official title | A Randomized, Open Label Trial to Assess the Steady State Pharmacokinetics of Avastin Given With Either XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | bevacizumab [Avastin], XELOX, FOLFOX-4 |
| Enrollment | 64 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jul 7, 2006 |
| Last update posted | Sep 18, 2012 |
| Countries | Australia, Canada, New Zealand |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: